107 related articles for article (PubMed ID: 12444553)
21. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
[TBL] [Abstract][Full Text] [Related]
22. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
23. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
24. CD117 expression in diffuse large B-cell lymphomas: fact or fiction?
Vakiani E; Cattoretti G; Colovai AI; Murty VV; Alobeid B; Bhagat G
Pathol Int; 2005 Nov; 55(11):716-23. PubMed ID: 16271084
[TBL] [Abstract][Full Text] [Related]
25. Composite recurrent hodgkin lymphoma and diffuse large B-cell lymphoma: one clone, two faces.
Huang Q; Wilczynski SP; Chang KL; Weiss LM
Am J Clin Pathol; 2006 Aug; 126(2):222-9. PubMed ID: 16891197
[TBL] [Abstract][Full Text] [Related]
26. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
27. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
Cotta CV; Leventaki V; Atsaves V; Vidaki A; Schlette E; Jones D; Medeiros LJ; Rassidakis GZ
Cancer; 2008 Feb; 112(3):552-61. PubMed ID: 18085637
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the chromosomal translocation t(11;18) in some mucosa-associated lymphoid tissue lymphomas and diffuse large B-cell lymphomas of the ocular adnexa: evidence from multiplex reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization on using formalin-fixed, paraffin-embedded specimens.
Takada S; Yoshino T; Taniwaki M; Nakamura N; Nakamine H; Oshima K; Sadahira Y; Inagaki H; Oshima K; Tadaatsu A
Mod Pathol; 2003 May; 16(5):445-52. PubMed ID: 12748251
[TBL] [Abstract][Full Text] [Related]
29. Hodgkin's lymphoma of T-cell type: clonal association with a CD30+ cutaneous lymphoma.
Kadin ME; Drews R; Samel A; Gilchrist A; Kocher O
Hum Pathol; 2001 Nov; 32(11):1269-72. PubMed ID: 11727269
[TBL] [Abstract][Full Text] [Related]
30. The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.
Schneider EM; Torlakovic E; Stühler A; Diehl V; Tesch H; Giebel B
J Pathol; 2004 Dec; 204(5):538-45. PubMed ID: 15538755
[TBL] [Abstract][Full Text] [Related]
31. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas.
Kluiver J; Poppema S; de Jong D; Blokzijl T; Harms G; Jacobs S; Kroesen BJ; van den Berg A
J Pathol; 2005 Oct; 207(2):243-9. PubMed ID: 16041695
[TBL] [Abstract][Full Text] [Related]
32. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
Iqbal J; Neppalli VT; Wright G; Dave BJ; Horsman DE; Rosenwald A; Lynch J; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Campo E; Ott G; Müller-Hermelink HK; Delabie J; Jaffe ES; Grogan TM; Connors JM; Vose JM; Armitage JO; Staudt LM; Chan WC
J Clin Oncol; 2006 Feb; 24(6):961-8. PubMed ID: 16418494
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features.
Balagué O; Martínez A; Colomo L; Roselló E; Garcia A; Martínez-Bernal M; Palacín A; Fu K; Weisenburger D; Colomer D; Burke JS; Warnke RA; Campo E
Am J Surg Pathol; 2007 Sep; 31(9):1310-22. PubMed ID: 17721185
[TBL] [Abstract][Full Text] [Related]
34. hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG.
Domínguez A; Ramos-Morales F; Romero F; Rios RM; Dreyfus F; Tortolero M; Pintor-Toro JA
Oncogene; 1998 Oct; 17(17):2187-93. PubMed ID: 9811450
[TBL] [Abstract][Full Text] [Related]
35. Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase.
Romero F; Multon MC; Ramos-Morales F; Domínguez A; Bernal JA; Pintor-Toro JA; Tortolero M
Nucleic Acids Res; 2001 Mar; 29(6):1300-7. PubMed ID: 11238996
[TBL] [Abstract][Full Text] [Related]
36. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical detection of multidrug resistance associated P-glycoprotein in stromal cells of malignant lymphomas.
Schlaifer D; Brousset P; Attal M; Voigt JJ; Laurent G; Delsol G
Nouv Rev Fr Hematol (1978); 1990; 32(5):365-7. PubMed ID: 1983081
[TBL] [Abstract][Full Text] [Related]
38. Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product.
Ramos-Morales F; Domínguez A; Romero F; Luna R; Multon MC; Pintor-Toro JA; Tortolero M
Oncogene; 2000 Jan; 19(3):403-9. PubMed ID: 10656688
[TBL] [Abstract][Full Text] [Related]
39. The expression of myc and ras oncogene protein in childhood lymphomas.
Sakalidou A; Kanavaros P; Tzardi M; Kalmanti M
Anticancer Res; 1996; 16(1):487-91. PubMed ID: 8615659
[TBL] [Abstract][Full Text] [Related]
40. Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues.
Narducci MG; Pescarmona E; Lazzeri C; Signoretti S; Lavinia AM; Remotti D; Scala E; Baroni CD; Stoppacciaro A; Croce CM; Russo G
Cancer Res; 2000 Apr; 60(8):2095-100. PubMed ID: 10786666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
